Department of Hematology and Oncology, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan; Division of Natural Drug Discovery, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Department of Chemistry, National Institute of Technology, Tiruchirappalli 620015, India.
J Inorg Biochem. 2018 May;182:208-221. doi: 10.1016/j.jinorgbio.2018.02.014. Epub 2018 Feb 24.
Three novel complexes (1, 3 and 4) ligating N-substituted isatin thiosemicarbazone derivatives have been synthesized and their structural and biological characteristics have been compared with those of the known analogs (2, 5-7 and 8). In addition, the structure of the representative ligands (L1, L3 and L4) and complex (4) was confirmed by single crystal X-ray diffraction method. All the complexes (1-8) were assessed for their cytotoxic property against a panel of four human cancer cells such as HepG-2 (liver), MOLM-14 (acute monocytic leukemia), U937 (histiocytic lymphoma). and IM-9 (myeloma). Complex 4 exhibited prominent cytotoxic property against MOLM-14, U937 and IM-9 cell lines. Moreover, the results were compared with the well-known anticancer drugs like doxorubicin, cisplatin and daunorubicin. Besides, complex 4 enhanced the apoptotic cell death in IM-9 cell line and induced cell cycle arrest at G1 phase. Western blot analysis revealed the down-regulation of Bcl-2 (b-cell lymphoma-2), up-regulation of Bax (bcl-2 associated X protein), release of cytochrome c and activation of caspases-3 in IM-9 cells by complex 4. Importantly, complex 4 was not toxic to the normal Vero cell line (IC > 300 μM). In addition, complex 4 showed the concentration dependent cleavage of supercoiled (SC) DNA to its nicked circular (NC) form.
已经合成了三个新的配合物(1、3 和 4),它们连接了 N-取代的靛红缩硫代氨基脲衍生物,并比较了它们与已知类似物(2、5-7 和 8)的结构和生物学特性。此外,通过单晶 X 射线衍射法确定了代表性配体(L1、L3 和 L4)和配合物(4)的结构。所有配合物(1-8)都被评估了对四种人类癌细胞(如 HepG-2(肝)、MOLM-14(急性单核细胞白血病)、U937(组织细胞淋巴瘤)和 IM-9(骨髓瘤))的细胞毒性。配合物 4 对 MOLM-14、U937 和 IM-9 细胞系表现出显著的细胞毒性。此外,结果与 doxorubicin、cisplatin 和 daunorubicin 等著名抗癌药物进行了比较。此外,配合物 4 增强了 IM-9 细胞系中的凋亡细胞死亡,并诱导细胞周期停滞在 G1 期。Western blot 分析显示,配合物 4 下调了 Bcl-2(b 细胞淋巴瘤-2),上调了 Bax(bcl-2 相关 X 蛋白),释放了细胞色素 c,并激活了 IM-9 细胞中的 caspase-3。重要的是,配合物 4 对正常的 Vero 细胞系(IC>300μM)没有毒性。此外,配合物 4 表现出对超螺旋(SC)DNA 的浓度依赖性切割,使其转化为缺口环状(NC)形式。